Abstract
The CDKN2/INK4A tumour suppressor gene is deleted or mutated in a large number of human cancers. Overexpression of its product, p16, has been shown to block the transition through the G1/S phase of the cell cycle in a pRb-dependent fashion by inhibiting the cyclin D-dependent kinases cdk4 and cdk6. Reconstitution of p16 function in transformed cells is therefore an attractive target for anti-cancer drug design.
| Original language | English |
|---|---|
| Pages (from-to) | 84-91 |
| Number of pages | 8 |
| Journal | Current biology : CB |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 1996 |
Keywords / Materials (for Non-textual outputs)
- Amino Acid Sequence
- Carrier Proteins
- Cell Cycle
- Cyclin-Dependent Kinase 4
- Cyclin-Dependent Kinase 6
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclin-Dependent Kinases
- Molecular Sequence Data
- Peptides
- Phosphorylation
- Protein-Serine-Threonine Kinases
- Proto-Oncogene Proteins
- Retinoblastoma Protein
- S Phase
Fingerprint
Dive into the research topics of 'Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver